Mireille Krier

793 total citations
15 papers, 328 citations indexed

About

Mireille Krier is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mireille Krier has authored 15 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Mireille Krier's work include Ubiquitin and proteasome pathways (4 papers), Computational Drug Discovery Methods (4 papers) and Peptidase Inhibition and Analysis (3 papers). Mireille Krier is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Computational Drug Discovery Methods (4 papers) and Peptidase Inhibition and Analysis (3 papers). Mireille Krier collaborates with scholars based in Germany, United States and France. Mireille Krier's co-authors include Didier Rognan, Guillaume Bret, Djordje Müsil, Timo Heinrich, Jörg Bomke, Felix Rohdich, Christina Esdar, Hartmut E. Greiner, Ulrich Grädler and João Xavier de Araújo‐Júnior and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Physical Chemistry Chemical Physics.

In The Last Decade

Mireille Krier

15 papers receiving 318 citations

Peers

Countries citing papers authored by Mireille Krier

Since Specialization

Citations

This map shows the geographic impact of Mireille Krier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireille Krier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireille Krier more than expected).

Fields of papers citing papers by Mireille Krier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireille Krier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireille Krier. The network helps show where Mireille Krier may publish in the future.

Co-authorship network of co-authors of Mireille Krier

This figure shows the co-authorship network connecting the top 25 collaborators of Mireille Krier. A scholar is included among the top collaborators of Mireille Krier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireille Krier. Mireille Krier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Synthesis and crystal structure of rac-2-(1,3-dioxoisoindolin-2-yl)ethyl 4-methyl-N-phenyl-N′-(triisopropylsilyl)benzenesulfondiimidoate: the first member of a new substance class 2022 ·Acta Crystallographica Section E Crystallographic Communications ·(unknown), Timo Heinrich, (unknown), Mireille Krier, (unknown), Michael Reggelin	2
2	Vibrational circular dichroism studies of exceptionally strong chirality inducers in liquid crystals 2021 ·Physical Chemistry Chemical Physics ·Mark A. J. Koenis, Valentin Paul Nicu, Lucas Visscher, Christian Collins Kuehn, Matthias Bremer, Mireille Krier, (unknown), Ulmas E. Zhumaev, Bernd Küstner, Wybren Jan Buma	5
3	Atropisomerism – A Neglected Way to Escape Out of Solubility Flatlands 2021 ·Journal of Pharmaceutical Sciences ·Christoph Saal, (unknown), Mireille Krier, Thomas Fuchß	10
4	Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting 2019 ·Journal of Cheminformatics ·Thierry Hanser, (unknown), Jeffrey Plante, Friedrich Rippmann, Mireille Krier	19
5	Abstract DDT02-01: First-time disclosure of M3258: A selective inhibitor of the immunoproteasome subunit LMP7 with potential for improved therapeutic utility in multiple myeloma compared to pan-proteasome inhibitors 2019 ·Michael J. Sanderson, Michael P. Busch, Christina Esdar, Manja Friese‐Hamim, Mireille Krier, Jianguo Ma, Djordje Müsil, Felix Rohdich, (unknown), Gina Walter, Ugo Zanelli, Oliver Schadt, Markus Klein	2
6	Abstract DDT02-01: First-time disclosure of M3258: A selective inhibitor of the immunoproteasome subunit LMP7 with potential for improved therapeutic utility in multiple myeloma compared to pan-proteasome inhibitors 2019 ·Cancer Research ·Michael P. Sanderson, Michael Busch, Christina Esdar, Manja Friese‐Hamim, Mireille Krier, Jianguo Ma, Djordje Müsil, Felix Rohdich, (unknown), Gina Walter, Ugo Zanelli, Oliver Schadt, Markus Klein	9
7	Abstract LB-054: Discovery and profiling of M3258, a potent and selective LMP7 inhibitor demonstrating high efficacy in multiple myeloma models 2019 ·Markus Klein, Michael P. Busch, Christina Esdar, Manja Friese‐Hamim, Mireille Krier, Djordje Müsil, Felix Rohdich, Michael P. Sanderson, Gina Walter, Oliver Schadt, Ugo Zanelli, Jianguo Ma	2
8	Abstract LB-054: Discovery and profiling of M3258, a potent and selective LMP7 inhibitor demonstrating high efficacy in multiple myeloma models 2019 ·Cancer Research ·Markus Klein, Michael Busch, Christina Esdar, Manja Friese‐Hamim, Mireille Krier, Djordje Müsil, Felix Rohdich, Michael P. Sanderson, Gina Walter, Oliver Schadt, Ugo Zanelli, Jianguo Ma	6
9	Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates 2016 ·Bioorganic & Medicinal Chemistry Letters ·Timo Heinrich, Hans‐Peter Buchstaller, (unknown), Felix Rohdich, Jörg Bomke, Manja Friese‐Hamim, Mireille Krier, Thorsten Knöchel, Djordje Müsil, Birgitta Leuthner, Frank T. Zenke	18
10	Fragment-based discovery of focal adhesion kinase inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Ulrich Grädler, Jörg Bomke, Djordje Müsil, (unknown), Martin Lehmann, Günter Hölzemann, Hartmut E. Greiner, Christina Esdar, Mireille Krier, Timo Heinrich	26
11	Fragment-Based Discovery of New Highly Substituted 1H-Pyrrolo[2,3-b]- and 3H-Imidazolo[4,5-b]-Pyridines as Focal Adhesion Kinase Inhibitors 2013 ·Journal of Medicinal Chemistry ·Timo Heinrich, Jeyaprakashnarayanan Seenisamy, Lourdusamy Emmanuvel, Santosh S. Kulkarni, Jörg Bomke, Felix Rohdich, Hartmut E. Greiner, Christina Esdar, Mireille Krier, Ulrich Grädler, Djordje Müsil	59
12	Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Hans‐Peter Buchstaller, Lars T. Burgdorf, Dirk Finsinger, Frank Stieber, Christian Sirrenberg, Christiane Amendt, Matthias Grell, Frank T. Zenke, Mireille Krier	17
13	Pharmacophore alignment search tool: Influence of canonical atom labeling on similarity searching 2010 ·Journal of Computational Chemistry ·Volker Hähnke, Matthias Rupp, Mireille Krier, Friedrich Rippmann, Gisbert Schneider	8
14	Assessing the Scaffold Diversity of Screening Libraries 2006 ·Journal of Chemical Information and Modeling ·Mireille Krier, Guillaume Bret, Didier Rognan	105
15	Design of Small-Sized Libraries by Combinatorial Assembly of Linkers and Functional Groups to a Given Scaffold: Application to the Structure-Based Optimization of a Phosphodiesterase 4 Inhibitor 2005 ·Journal of Medicinal Chemistry ·Mireille Krier, João Xavier de Araújo‐Júnior, Martine Schmitt, (unknown), (unknown), Claire Lugnier, Jean‐Jacques Bourguignon, Didier Rognan	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact